Inquiry Basket
Loading ......
Filter By Product Search for
CUL5
CUL5 Full Name
cullin 5
CUL5 Introduction
CUL5 (cullin 5) is a member of the Cullin-RING E3 ubiquitin ligase family and serves as the scaffold protein of the Cullin-RING Ligase 5 (CRL5) complex, a key regulator of selective protein degradation through the ubiquitin-proteasome system. Researchers studying signal transduction, immune regulation, and cancer progression often encounter CUL5 because of its central role in controlling protein turnover and maintaining cellular homeostasis. By interacting with Elongin B/C adaptors and SOCS-box-containing substrate receptors, CUL5 enables the recognition and ubiquitination of specific target proteins. Recent reviews have highlighted that CUL5 activity is tightly controlled by NEDD8-mediated neddylation, a modification that determines the assembly and activation of CRL5 complexes. Beyond its traditional role in proteostasis, CUL5 has emerged as a multifunctional regulator involved in autophagy, DNA damage repair, mitochondrial homeostasis, and cell-cycle progression, making it an increasingly important target for researchers seeking new therapeutic opportunities.
Understanding the biological functions of CUL5 has become particularly relevant for investigators exploring immune signaling and cell fate decisions. Accumulating evidence demonstrates that CUL5 participates in the fine-tuning of cytokine signaling pathways and helps maintain the balance between cellular proliferation, differentiation, and immune responses. Recent mechanistic studies revealed that CUL5 acts as a negative regulator of CD8+ T-cell activity, suppressing T-cell receptor (TCR) and IL-2 signaling through interactions with SOCS-box proteins such as PCMTD2. Loss of CUL5 significantly enhances the antitumor capacity and persistence of cytotoxic T cells, suggesting that CRL5 inhibition may complement current immunotherapy strategies. In parallel, emerging studies have shown that CUL5 is essential for maintaining hematopoietic stem cell homeostasis. Disruption of CUL5 function in mouse models leads to excessive stem cell expansion, abnormal myeloid differentiation, and dysregulated STAT5 signaling, indicating that the CUL5-LRRC41 axis is a critical component of normal hematopoiesis. These findings have expanded the understanding of CRL5 from a protein degradation machinery to a broader regulator of immune cell biology and tissue homeostasis.
Abnormal CUL5 expression or dysfunction has been associated with numerous human diseases, particularly cancer and hematological disorders. Altered CUL5 levels have been reported in colorectal cancer, gastric cancer, renal cell carcinoma, glioblastoma, and several other malignancies, where the protein may function either as a tumor suppressor or as a context-dependent regulator of oncogenic signaling pathways. Because CUL5 influences the stability of proteins involved in apoptosis, DNA repair, and cell survival, dysregulation of CRL5 activity can contribute to tumor progression, therapeutic resistance, and immune evasion. Recent studies have also linked CUL5-mediated signaling abnormalities to disorders of hematopoiesis characterized by leukocytosis, anemia, thrombocytosis, and extramedullary hematopoiesis. The growing understanding of CUL5 biology has generated substantial interest in targeting the ubiquitin-proteasome system and CRL5-associated pathways. As a result, CUL5 is increasingly recognized as a promising biomarker and therapeutic target for cancer immunotherapy, hematologic diseases, and precision medicine approaches aimed at restoring controlled protein homeostasis and cellular signaling.
Alternate Names for CUL5
CUL5; cullin 5; CUL-5; PHA2E; cullin-5; cullin5
Loading ......
